MedTrace Logo

Bioavailability of Hydroxytyrosol From Olive Watery Extract Supplements

NCT04876261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2021-07-14

No results posted yet for this study

Summary

The aim of this cross-over study is to assess the bioavailability of hydroxytyrosol in healthy males after the intake of two olive watery extract supplements and one olive oil. Blood and urine samples will be collected before and after intake of the investigational products. Sample will be analysed regarding the level of hydroxytyrosol and preventing lipid peroxidation.

Conditions

  • Biological Availability

Interventions

DIETARY_SUPPLEMENT

Oliphenolia® bitter

* ingredients: concentrated watery extract of olives 94%, lemon juice 6% * 35 mg hydroxytyrosol, 0,24 mg Oleuropein

DIETARY_SUPPLEMENT

Oliphenolia®

* ingredients: grape juice concentrate 70%, concentrated watery extract of olives 30% * 38 mg hydroxytyrosol, 0,28 mg Oleuropein

DIETARY_SUPPLEMENT

La Vialla Extra Virgin Olive Oil containing 5 mg hydroxytyrosol

* extra virgin olive oil * 5 mg hydroxytyrosol

Sponsors & Collaborators

  • ISTITUTO KURZ ITALIA S.R.L.

    collaborator UNKNOWN

  • Institut Kurz GmbH

    collaborator UNKNOWN

  • Fattoria La Vialla di Gianni, Antonio e Bandino Lo Franco Soc. Agr. Sempl.

    collaborator UNKNOWN

  • Daacro

    lead NETWORK

Principal Investigators

  • Juliane Hellhammer, PhD · Daacro

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2021-07-02
Completion
2021-07-02

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04876261 on ClinicalTrials.gov